DUO-PHARMA
ActiveDUO-PHARMA has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €61k and a net result of €28k. Equity is growing by ~18% per year across the filed fiscal years. Its solvency ranks better than 22% of 10206 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+26
Solvency18▼-52
Growth58▼-20
Stability100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3k at 30 days only on tighter terms
Liquidity short (current ratio 0.91 against 1.5 in 2024), and 87.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
12.8%
Return on assets
5.9%
Age of the figures
8 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 10206 sector peers (2025).
NBB · sector comparisonPosition among 10206 sector peers
Solvency
better than 22%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
17 d early
2023
23 d late
2022
20 d early
2021
18 d early
2020
11 d early
2019
25 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
12-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€28k▼ 0.1%
2024 · €28k
2018: €10k
2019: €3k
2020: €17k
2021: €24k
2022: €30k
2023: €37k
2024: €28k
2018 → 2025
Working capital
€-27k
2024 · €86k
2018: €47k
2019: €47k
2020: €54k
2021: €67k
2022: €73k
2023: €92k
2024: €86k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€115k-€135k▲ 17.0%€172k▲ 27.7%€191k▲ 10.6%€61k▼ 67.9%
Operating result€37k-€44k▲ 17.8%€53k▲ 20.8%€41k▼ 23.2%€41k▼ 0.6%
Net result€24k-€30k▲ 23.2%€37k▲ 26.4%€28k▼ 24.5%€28k▼ 0.1%
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 1% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €479k
Fixed assets
€194k▼ 22.1%
Current assets
€285k▲ 10.9%
Equity and liabilities €479k
Equity
€61k▼ 67.9%
Debt
€418k▲ 32.5%
The debt ratio rises from 62.3% to 87.2%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€96k▲
2024 · €95k
Cash flow
€83k▲
2024 · €82k
Solvency
12.8%▼
2024 · 37.7%
Current ratio
0.91▼
2024 · 1.50
Quick ratio
0.52▼
2024 · 0.79
Debt / equity
6.83▲
2024 · 1.66
ROE
46.1%▲
2024 · 14.8%
ROA
5.9%▲
2024 · 5.6%
Interest coverage
26.00▲
2024 · 22.11
Debt
€418k▲
2024 · €315k
Debt ≤ 1 year
€312k▲
2024 · €171k
Debt > 1 year
€105k▼
2024 · €144k
Income taxes
€9k▲
2024 · €8k
Staff costs
€48k▲
2024 · €47k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€506k€479k▼
Fixed assets21/28€249k€194k▼
Intangible fixed assets21€41k€8k▼
Tangible fixed assets22/27€208k€186k▼
Land and buildings22€197k€177k▼
Plant, machinery and equipment23€9k€8k▼
Furniture and vehicles24€2k€787▼
Current assets29/58€257k€285k▲
Stocks and contracts in progress3€123k€124k▲
Stocks30/36€123k€124k▲
Amounts receivable within one year40/41€45k€57k▲
Trade receivables40€41k€51k▲
Other amounts receivable41€4k€6k▲
Cash at bank and in hand54/58€87k€102k▲
Deferred charges and accrued income490/1€2k€2k▼
Equity and liabilities
Total equity and liabilities10/49€506k€479k▼
Equity10/15€191k€61k▼
Contributions10/11€33k€33k=
Profit (loss) carried forward14€158k€28k▼
Amounts payable17/49€315k€418k▲
Amounts payable after more than one year17€144k€105k▼
Financial debts170/4€144k€105k▼
Amounts payable within one year42/48€171k€312k▲
Current portion of amounts payable after more than one year42€69k€44k▼
Trade debts44€56k€70k▲
Suppliers440/4€56k€70k▲
Taxes, remuneration and social security45€8k€31k▲
Taxes450/3€1k€24k▲
Remuneration and social security454/9€7k€7k▲
Other amounts payable47/48€37k€167k▲
Accrued charges and deferred income492/3€1k€988▼
Income statement
Code20242025
Remuneration, social security and pensions62€47k€48k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€54k€55k▲
Other operating charges640/8€2k€2k▲
Gross operating margin9900€143k€145k▲
Operating profit (loss)9901€41k€41k▼
Financial income75/76B€7€0▼
Recurring financial income75€7€0▼
Financial charges65/66B€4k€4k▼
Recurring financial charges65€4k€4k▼
Profit (loss) for the period before taxes9903€37k€37k▲
Income taxes67/77€8k€9k▲
Profit (loss) for the period9904€28k€28k▼
Profit (loss) for the period to be appropriated9905€28k€28k▼
Appropriation of the result
Profit (loss) to be appropriated9906€168k€186k▲
Profit (loss) brought forward from the previous period14P€139k€158k▲
Transfer from equity791/2€0-
Profit to be distributed694/7€10k€158k▲
Return on contributions (dividend)694€10k€158k▲
Social balance
Average headcount (FTE)90870.80.0▼
The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
14-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
23-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 23 days late
2023
31-12
Financial
Highest result since 2018net €37k ▲26.4%
Operating result €53k, net result €37k, both a record.
31-12
Financial
Equity above €150kEq €172k ▲27.7%
6 profitable years in a row build equity to €172k.
11-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
13-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Equity above €100kEq €115k ▲26.3%
4 profitable years in a row build equity to €115k.
20-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
25-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 25 days late
2019
31-12
Financial
Weakest financial yearnet €3k ▼68%
Net result drops to €3k, the lowest in the series; recovery starts the following year.
09-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 9 days late
2018
09-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
28-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Orp-Jauche · 1 establishment unit since 2016
Ground area
152 m²
Building footprint
63 m²
Volume, LiDAR
652 m³
Parcel 25046B0179/00S002, Wallonia · tallest building 11.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
DUO-PHARMA
since 20162.252.506.086
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25046B0179/00S002 | Wallonia | 152 m² | 1 · 63 m² | 11.3 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Apotheek Leemans-Vanheusden
BE 0454.490.332
Bilzen-Hoeselt · Eq €61k
DE SERVICE APOTHEEK
BE 0824.688.852
Sint-Truiden · Eq €61k
VAN AELST LEONIE
BE 0804.185.131
Beernem · Eq €61k
HUBERT SERVICES MANAGEMENT
BE 0774.338.330
Estinnes · Eq €61k
Pharmacie Simon Collard
BE 0791.374.696
Waremme · Eq €61k
Of 5,208 companies in sector 47730 we hold annual accounts for 3,850. 2,981 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded07-04-2016
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
47750Retail sale of cosmetics and toilet articles
47789Other retail sale of new goods
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers
Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.